Benjamin Dieplinger
Dados Biográficos
| ID | 7924645 |
|---|---|
| NOME | Benjamin Dieplinger |
| PRENOMES | Benjamin |
| SOBRENOME | Dieplinger |
| ASSINATURA | DIEPLINGER B |
| AFILIAÇÕES | Convent Hospital of the Brothers of Saint John of God |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2022 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2022 |
| ÍNDICE H | 0 |
High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with Covid-19 Vaccine Breakthrough Infection
In this retrospective data analysis, we show that almost all patients who died from COVID-19 vaccine breakthrough infection had antibody levels < 600 U/mL, most of them below 200 U/mL. In logistic regression corrected for the number of comorbidities and age, anti-CoV2S antibody levels at the time of hospitalization proved to be a significantly protective predictor against death
Sem obras proeminentes nesta página.
High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with Covid-19 Vaccine Breakthrough Infection
In this retrospective data analysis, we show that almost all patients who died from COVID-19 vaccine breakthrough infection had antibody levels < 600 U/mL, most of them below 200 U/mL. In logistic regression corrected for the number of comorbidities and age, anti-CoV2S antibody levels at the time of hospitalization proved to be a significantly protective predictor against death
2019-20 coronavirus outbreak (1 obra) · Antibody (1 obra) · Coronavirus disease 2019 (COVID-19 (1 obra) · COVID-19 Clinical Research Studies (1 obra) · Disease (1 obra) · Immunology (1 obra) · Infectious disease (medical specialty (1 obra) · Internal Medicine (1 obra) · Long-Term Effects of COVID-19 (1 obra) · Medicine (1 obra)